2.23. Analysis.
Comparison 2 RISPERIDONE + CLOZAPINE vs PLACEBO + CLOZAPINE, Outcome 23 Adverse effects: 8. sleep ‐ skewed data ‐ average change score (UKU) ‐ short term (up to 12 weeks).
Adverse effects: 8. sleep ‐ skewed data ‐ average change score (UKU) ‐ short term (up to 12 weeks) | ||||
---|---|---|---|---|
Study | Intervention | Mean | SD | N |
Yagcioglu 2005 | Risperidone | 0.7 | 0.36 | 16 |
Yagcioglu 2005 | Placebo | 0.2 | 0.37 | 14 |